Evening Dosing Is Associated With Higher Plasma Concentrations of Pranlukast, a Leukotriene Receptor Antagonist, in Healthy Male Volunteers
British Journal of Clinical Pharmacology - United Kingdom
doi 10.1046/j.1365-2125.1997.00650.x
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 2, 2003
Authors
Publisher
Wiley